EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ranalexin-1G: A Promising Antimicrobial Peptide Targeting Virulence and Host–Pathogen Interactions in Pseudomonas aeruginosa In Vitro Models

Marina Acunzo iD, Carla Zannella iD, Rosa Giugliano iD, Laura Di Clemente iD, Carla Capasso iD, Annalisa Chianese iD, Maria Andriolo, Federica Donadio, Emanuela Esposito iD, Alessandra Monti iD, Nunzianna Doti iD, Teresa Maria Assunta Fasciana und 3 weitere

Antibiotics · 22.07.2026 · 15 (7) · 711

DOI: 10.3390/antibiotics15070711 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 22.07.2026. Verfasst von Marina Acunzo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Woman, Child and General and Specialized Surgery, University of Campania Luigi Vanvitelli, 80138 Naples, Italy. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lung infections represent a major cause of morbidity and mortality in patients with cystic fibrosis (CF) and are predominantly associated with chronic infection by Pseudomonas aeruginosa. The clinical management of CF lung disease is increasingly compromised by the emergence of multidrug-resistant strains, biofilm formation, and the expression of multiple virulence determinants. Antimicrobial peptides (AMPs), evolutionarily conserved effectors of innate immunity, have emerged as promising therapeutic candidates due to their ability to exert both bactericidal and anti-virulence activities. In this study, we investigated the antimicrobial and mechanistic effects of Ranalexin-1G, an AMP derived from the skin secretion of Rana grylio, against P. aeruginosa, for which its antibacterial activity has not previously been reported in the literature.

Methods

Antibacterial activity was determined against the reference strain and three clinical isolates of P. aeruginosa by broth microdilution assays, time-kill kinetics and anti-biofilm assays, while peptide-mediated modulation of virulence was evaluated through transcriptional analysis of key virulence-associated genes by RT-PCR. The impact of Ranalexin-1G on host–pathogen interactions was further assessed using bacterial invasion assays in human bronchial epithelial cells (BEAS-2B).

Results

Ranalexin-1G exerted a rapid bactericidal effect within 6 h at non-cytotoxic concentrations and displayed modest anti-biofilm effects, with greater efficacy in inhibiting biofilm formation. Mechanistically, peptide treatment resulted in a reduction in the expression of selected genes involved in biofilm formation and virulence, including those associated with alginate biosynthesis and type III secretion system-mediated cytotoxicity. Consistently, Ranalexin-1G markedly impaired bacterial invasion of epithelial cells, indicating interference with early host–pathogen interaction processes. Notably, the peptide displayed robust antimicrobial activity against multidrug-resistant P. aeruginosa clinical isolates from CF patients.

Conclusions

Collectively, these findings suggest that Ranalexin-1G acts through a dual mechanism involving direct bactericidal activity and modulation of selected virulence pathways, supporting further investigation of its potential as an anti-virulence and host-directed approach for the treatment of chronic P. aeruginosa infections in cystic fibrosis.

Schlagwörter

Stichwörter der Autor:innen

Pseudomonas aeruginosaantibacterialantimicrobial peptidescystic fibrosis isolateshost–pathogen interaction

Autor:innen und Institutionen

  • Department of Woman, Child and General and Specialized Surgery, University of Campania Luigi Vanvitelli, 80138 Naples, Italy.
  • UOC Virology and Microbiology, University Hospital "Luigi Vanvitelli", 80138 Naples, Italy.
  • Department of Life Sciences, Health and Health Professions, Link Campus University, 00165 Rome, Italy.
  • Clinical Pathology Unit, Sant' Elia Hospital, 93100 Caltanissetta, Italy.
  • Institute of Applied Sciences and Intelligent Systems (ISASI), National Research Council (CNR), Naples Cryo-Electron Microscopy Laboratory (M6.1 EYE LAB), Via Pietro Castellino 111, 80131 Naples, Italy.
  • Institute of Biostructures and Bioimaging (IBB), National Research Council (CNR), 80131 Naples, Italy.

ORCID-Profile: Marina Acunzo, Carla Zannella, Rosa Giugliano, Laura Di Clemente, Carla Capasso, Annalisa Chianese, Emanuela Esposito, Alessandra Monti, Nunzianna Doti, Massimiliano Galdiero, Anna De Filippis

Zitieren

APA

Acunzo, M., Zannella, C., Giugliano, R., Di Clemente, L., Capasso, C., Chianese, A., Andriolo, M., Donadio, F., Esposito, E., Monti, A., Doti, N., Fasciana, T. M. A., Giammanco, A., Galdiero, M., & Filippis, A. (2026). Ranalexin-1G: A Promising Antimicrobial Peptide Targeting Virulence and Host–Pathogen Interactions in Pseudomonas aeruginosa In Vitro Models. Antibiotics, 15(7), 711. https://doi.org/10.3390/antibiotics15070711

Vancouver

Acunzo M, Zannella C, Giugliano R, Di Clemente L, Capasso C, Chianese A, et al. Ranalexin-1G: A Promising Antimicrobial Peptide Targeting Virulence and Host–Pathogen Interactions in Pseudomonas aeruginosa In Vitro Models. Antibiotics. 2026;15(7):711. doi:10.3390/antibiotics15070711

BibTeX
@article{Acunzo2026,
  author = {Acunzo, Marina and Zannella, Carla and Giugliano, Rosa and Di Clemente, Laura and Capasso, Carla and Chianese, Annalisa and Andriolo, Maria and Donadio, Federica and Esposito, Emanuela and Monti, Alessandra and Doti, Nunzianna and Fasciana, Teresa Maria Assunta and Giammanco, Anna and Galdiero, Massimiliano and Filippis, Anna De},
  title = {Ranalexin-1G: A Promising Antimicrobial Peptide Targeting Virulence and Host–Pathogen Interactions in Pseudomonas aeruginosa In Vitro Models},
  journal = {Antibiotics},
  year = {2026},
  volume = {15},
  number = {7},
  pages = {711},
  doi = {10.3390/antibiotics15070711}
}
Kostenlos starten →